• Home
  • Dr. Berenson
    • Staff
  • Multiple Myeloma Q&A
  • Testimonials
    • Patient Testimonials
      • Maureen V
    • Video Testimonials
  • Articles
    • Archives
  • Contact
    • Becoming a Patient
    • Registration Form
Subscribe: Posts | Comments
James R. Berenson, MD, Inc. Berenson Oncology
  • Broadcasts
  • Movie Premier
  • Papers
  • Press Releases
  • Videos
  •  
RSS

Multiple Myeloma Q&A


Video Series

  1. Introduction
  2. How do you know if you have multiple myeloma?
  3. How do the doctors decide what treatment to use for your myeloma?
  4. What are the types of therapies that are used to treat myeloma?
  5. How do you know if the treatment is working? Part 1
  6. How do I know if the treatment is working? Part 2
  7. At what point do you need to change your treatment?
  8. What are the specific drugs used to treat myeloma?
  9. Chemotherapy and steroids
  10. Velcade
  11. Lenalidomide
  12. Arsenic trioxide
  13. Clinical Research
  14. Bone Disease
  15. Nerve Problems
  16. Kidney Disease
  17. Anemia

James R. Berenson, MD

James R. Berenson, MD

 

President and CEO - James R. Berenson, MD, Inc.
Medical & Scientific Director - Institute for Myeloma
     & Bone Cancer Research (IMBCR)
Chief Executive Officer - Oncotherapeutics

  • Latest
  • Popular
  • Comments
  • Tags
  • Love Is All You Need – Movie Premiere Benefiting the Institute for Myeloma & Bone Cancer Research March 28, 2013
  • Phase I/II trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myeloma February 19, 2013
  • CEP-18770 (delanzomib) in combination with dexamethasone and lenalidomide inhibits the growth of multiple myeloma November 19, 2012
  • Myeloma Cure Panel Broadcast – Dr. James Berenson will discuss Multiple Myeloma disease control Without Transplant November 9, 2012
  • Updates in the Treatment of Multiple Myeloma October 26, 2012
  • Kyphon® Balloon Kyphoplasty Found Beneficial for Treating Spinal Fractures in Cancer Patients February 16, 2011
  • Phase I/II trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myeloma February 19, 2013
  • CEP-18770 (delanzomib) in combination with dexamethasone and lenalidomide inhibits the growth of multiple myeloma November 19, 2012
  • Myeloma Cure Panel Broadcast – Dr. James Berenson will discuss Multiple Myeloma disease control Without Transplant November 9, 2012
  • Updates in the Treatment of Multiple Myeloma October 26, 2012
BCMA Dedication IMBCR Multiple Myeloma Revlimid Secondary Cancers

Links

  • American Cancer Society
  • American Society of Clinical Oncology
  • American Society of Hematology
  • Cancer Support Community
  • Institute for Myeloma & Bone Cancer Research
  • Leukemia & Lymphoma Society®
  • National Institutes of Health
  • Oncotherapeutics

Subscribe

Subscribe to our e-mail newsletter to receive updates.

Contact Us

9201 W. Sunset Blvd. Ste. 310
West Hollywood, CA 90069
Tel  (310) 623-1222
Fax (310) 623-1122
info@berensononcology.com

Sunset Medical Plaza
© 2012 James R. Berenson, MD, Inc..
All rights reserved.
Website Design by TG.
Admin